EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Down 38.5% in July

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totaling 24,493 shares, a drop of 38.5% from the June 30th total of 39,841 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 180,734 shares, the days-to-cover ratio is presently 0.1 days.

Analyst Ratings Changes

A number of research analysts have recently commented on ESLOY shares. Zacks Research downgraded shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd. The Goldman Sachs Group cut shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a report on Tuesday, July 14th. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on EssilorLuxottica in a report on Tuesday, May 12th. They set a “hold” rating for the company. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy”.

EssilorLuxottica Trading Down 2.7%

ESLOY opened at $94.42 on Thursday. EssilorLuxottica has a 1-year low of $91.44 and a 1-year high of $186.81. The stock’s fifty day simple moving average is $98.57 and its 200 day simple moving average is $117.79. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.